[HTML][HTML] Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
DN Streblow, AJ Hirsch, JJ Stanton, AD Lewis… - Nature …, 2023 - nature.com
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology.
DN Streblow, AJ Hirsch, JJ Stanton… - Nature …, 2023 - europepmc.org
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
DN Streblow, AJ Hirsch, JJ Stanton… - Nature …, 2023 - econpapers.repec.org
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology.
D Streblow, A Hirsch, J Stanton, A Lewis… - Nature …, 2023 - escholarship.org
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
DN Streblow, AJ Hirsch, JJ Stanton… - Nature …, 2023 - ohsu.elsevierpure.com
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology.
DN Streblow, AJ Hirsch, JJ Stanton… - Nature …, 2023 - search.ebscohost.com
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
DN Streblow, AJ Hirsch, JJ Stanton… - Nature …, 2023 - ideas.repec.org
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
DN Streblow, AJ Hirsch, JJ Stanton… - Nature …, 2023 - pubmed.ncbi.nlm.nih.gov
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
DN Streblow, AJ Hirsch, JJ Stanton… - Nature …, 2023 - ui.adsabs.harvard.edu
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
[HTML][HTML] Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
DN Streblow, AJ Hirsch, JJ Stanton… - Nature …, 2023 - ncbi.nlm.nih.gov
Passively administered monoclonal antibodies (mAbs) given before or after viral infection
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …
can prevent or blunt disease. Here, we examine the efficacy of aerosol mAb delivery to …